[MUSIC PLAYING]

The Netflix show Pandemic has 
been getting a lot of attention

lately-- one of the 
scientists featured

in the show who is 
now working on a drug

to treat COVID-19 patients.

It is a golden age 
in biotechnology.

I'm Jacob Glanville.

I'm the co-founder 
and chief science

officer of Distributed Bio.

You know, each one 
of the people that

come from USF that's on my team 
are different and remarkable

in various ways.

And what we try to 
do at Distributed Bio

is spot incredible people and 
enable them to succeed here.

I'm Sarah Ives.

I graduated from the USF 
Biotechnology PSM program

in 2015.

Here at Distributed Bio, I'm 
leading the vaccine project,

the universal influenza vaccine.

The fact that our 
technology is not

meant to only work 
on influenza, this

could be applicable to HIV, 
flaviviruses, coronaviruses.

We could make the last 
flu shot you'll ever get.

The curriculum at 
USF sets students up

to be able to hit 
the ground running

in a biotech or a large pharma 
where people expect someone

to be able to wear many hats.

The University of 
San Francisco is

situated right in the 
middle of Silicon Valley

and the birthplace 
of biotechnology here

in South San Francisco and the 
work done throughout the area.

So people who are working in 
a cool city, of San Francisco,

are able to network with a 
large number of companies,

really unprecedented 
anywhere else,

and gain the kinds 
of exposure to let

them know what sort of 
jobs they're interested in

and the ability to go find 
them immediately afterwards.

I definitely felt like 
the network at USF

provided us with 
ample opportunity

to get internships and jobs.

It's like, wow, we're 
actually making something

that is going to help people.

It's just a matter of when.

[MUSIC PLAYING]